Kotak Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Kotak Healthcare Fund - Regular (G)
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹231 Cr | ₹482 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 11 Dec 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | NIFTY Healthcare TRI |
| Turn Over | % | % |
| Expense Ratio | 2.35 | 2.39 |
| Manager | Rohan Korde | Abhishek Bisen |
| ISIN Code | INF00XX01BL5 | INF174KA1PW4 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Kotak Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Month | -1.22% | -1.71% |
| 6 Month | -1.35% | 1.61% |
| 1 Year | -7.23% | -4.7% |
| 3 Year | 18.74% | - |
| 5 Year | - | - |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| 6 Month | -3.88% | -2.75% |
| 1 Year | -3.89% | 0.81% |
| 3 Year | 13.18% | - |
| 5 Year | - | - |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Year | 18.94% | 13.51% |
| 3 Year | 20.21% | - |
| 5 Year | - | - |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Standard Deviation | 15.68% | - |
| Sharp | 0.75% | - |
| Beta | 0.95% | - |
| Alpha | -3.33% | - |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Name | Rohan Korde | Abhishek Bisen |
| Total AUM | ₹4626 Cr | ₹0 Cr |
| Funds Managed | 10 | 33 |
| ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 4.69 | 9.77 |
| Large Cap | 31.32 | 28.76 |
| Mid Cap | 36.99 | 31.98 |
| Small Cap | 27.01 | 29.49 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 2.72 | 0.97 |
| Healthcare | 92.93 | 95.6 |
| Industrials | 0.97 | - |
| Financial Services | 1.26 | - |
| Basic Materials | 2.12 | 3.43 |
Top Comparisons
Kotak Equity Savings Fund - Regular - Growth
3Y Returns11.95%
Tata Equity Savings Fund -Regular Plan-Growth Option
3Y Returns10.17%
DSP Liquidity Fund - Regular Plan - Growth
3Y Returns6.95%
Quant Liquid Fund-Growth
3Y Returns6.67%
ICICI Prudential Dividend Yield Equity Fund Growth Option
3Y Returns24.05%
Aditya Birla Sun Life Dividend Yield Fund - Growth - Regular Plan
3Y Returns20.84%
DSP Global Innovation Overseas Equity Omni FOF - Regular - Growth
3Y Returns31.81%
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth
3Y Returns38.46%